CTRI/2020/04/024785Not yet recruiting未知
Clinical and Radiographic evaluation of calcium sulfate hemihydrate bone graft (Dentogen) with hyaluronic acid and calcium sulfate hemihydrate bone graft (Dentogen) alone in the treatment of infrabony defects in chronic periodontitis
JUWERIA WAJID0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Age group is 18-55 years.
- •2.Minimum 20 permanent teeth should be present.
- •3.Periodontal pocket depth >= 5mm.
- •4.Atleast one site with radiographic infrabony defect assessed by IOPA.
Exclusion Criteria
- •1.Systemically compromised patients and those on medications (corticosteroids/ Bisphosphonate) that may interfere with wound healing.
- •2.Pregnant women and lactating mother.
- •3.Active periodontal treatment with in last 6 month.
- •4.Smokers.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial to study the new formation of lost bone supporting the teeth, by placing calcium phosphate bone graft.CTRI/2020/11/028807JSSAHER
Recruiting
Not Applicable
Clinical evaluation of the influence of calcium and fluoride based mouthrinses in reducing tooth sensitivity and the effectiveness of color change during in-office bleachingRBR-46vshgSão Leopoldo Mandic
Completed
Phase 3
Comparative evaluation of the efficacy of calcium hydroxide with resin modified glass ionomer versus TheraCal in indirect pulp cap: a clinical trial studyIRCT20231025059853N1Shahre-kord University of Medical Sciences50
Not yet recruiting
Phase 2
comparative evaluation of three different root canal medicaments in reducing paiCTRI/2024/08/071970Dr Itika Jain
Active, not recruiting
Not Applicable
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidismEUCTR2010-018861-53-NLeiden University Medical Center